Navigation Links
ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
Date:12/6/2011

andidates in its pipeline that target multiple areas of significant unmet medical need. For more information visit www.halozyme.com.

ViroPharma Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including the therapeutic indication and use, safety, efficacy, tolerability and potential of Cinryze and our focus, goals, strategy, research and development programs, and ability to develop pharmaceutical products, commercialize pharmaceutical products, and execute on our plans including clinical development activities with Cinryze related to subcutaneous administration.

The safety, pharmacokinetics and pharmacodynamics data described in this press release are preliminary and additional review of the data may reveal additional findings which may not be consistent with this press release. The data described in this press release may not be predictive of the results of future studies and there can be no assurance that that future studies with Cinryze utilizing subcutaneous administration in combination with rHuPH20 will yield positive results or support further development of Cinryze for subcutaneous administration in combination with rHuPH20. The FDA or EMA may view the data regarding subcutaneous administration of Cinryze in combination with rHuPH20 as insufficient or inconclusive, request additional data, require additional clinical studies, delay any decision past the time frames anticipated by us, limit any approved indications, or deny the approval of Cinryze for subcutaneous administration in combination with rHuPH20. These factors, and other factors, including, but not limited to those described in our annual report on Form 10-K for the year ended December 31, 2010 and quarterly reports on Form 10-Q filed wit
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ViroPharma to Participate in Two November Healthcare Investor Conferences
2. ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline
3. ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
4. ViroPharma to Release 2011 Third Quarter Financial Results on October 27, 2011
5. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
6. ViroPharma Announces Additional Securities Repurchase Program
7. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
8. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
9. ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
10. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
11. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)...  Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, ... announced that its Chairman and CEO, Alan Shortall ... 26th Annual Healthcare Conference at the New York Palace ... 2014. The conference presentation will be ... Webcast. To listen, please go to: http://ir.unilife.com/events.cfm . ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
(Date:11/27/2014)... PA (PRWEB) November 27, 2014 An ... from an embarrassing fact of life, and she wants ... a few minutes later, I decided that there needed ... periods," she said. , Easy to use and producible ... freshness in a woman’s private areas throughout the day. ...
(Date:11/27/2014)... Most babies and young children don,t need medicines if ... Administration says. Over-the-counter (OTC) cold and cough medicine ... because they could cause serious and potentially deadly side ... three colds a year, but children get them more ... to give them pain relievers, decongestants and other medicines, ...
(Date:11/27/2014)... The founders of VIM & VIGR, a company that ... socks, are proud to announce the debut of their new ... (TM) knitting technology that is designed to increase the circulation ... adding flair and style to a product that has traditionally ... of a writer at The New York Times . ...
(Date:11/27/2014)... CA (PRWEB) November 27, 2014 Two ... dental implants procedure will help one person with ... , Dr. Saj Jivraj and Dr. Mamaly Reshad of ... Hills, Calif., have launched a website devoted to helping ... section of the website would be devoted to helping ...
(Date:11/27/2014)... Developers and plugin specialist of Final Cut Pro X ... to the next level. , “ProPip allows users to create ... a mouse,” said Christina Austin, CEO of Pixel Film Studios. ... , With ProPip users can show off their media ... is great for commentaries, news casting, and more. PROPIP™ gives ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3
... April 2, 2008 The National,Association of Realtors(R) ... Olympia Snowe, R-Maine; and Norm Coleman, R-Minn.,as they ... NAR,supports and endorses the program but reiterates the ... small businesses and independent,contractors., A recently conducted ...
... car crashes where baby is injured or dies are unbelted 62% ... to some popular folklore, pregnant women should wear seat ... car accident but also to save their fetus. , According to ... American Journal of Obstetrics & Gynecology , almost 200 fetuses each ...
... Former Health and Cooking Light editor will lead landmark launch. ... balance fits the magazine,s ethos., NEW YORK, April 2, ... Spry, the largest health magazine launch in history,scheduled for September ... editor of Cooking Light and Prevention, she brings,more than 15 ...
... , What: PocketCPR(TM), an FDA-cleared, ... in the delivery of high-quality cardiopulmonary ... compressions alone, or hands-only cardiopulmonary resuscitation ... students in Arizona. (Photo: ...
... of Physicians (ACP), along with other national, state, and ... Set for April 16, 2008, the initiative encourages all ... talk to their family or doctor about their wishes, ... in a living will, and for providers and facilities ...
... Mrs. Jane M. Knight, of,Hampton, Virginia, has been ... her outstanding contributions and achievements in the,field of ... About Mrs. Jane M. Knight, Mrs. Knight ... and women,s health. She was Nurse-Midwife with the,USAF ...
Cached Medicine News:Health News:U.S. Health Care System Must Be Reformed, Say Nine Out of 10 Realtors(R) 2Health News:Seat Belt Use by Pregnant Women Could Save 200 Fetuses a Year 2Health News:Seat Belt Use by Pregnant Women Could Save 200 Fetuses a Year 3Health News:Spry Names Lisa Delaney Editor in Chief 2Health News:State of Arizona to Use PocketCPR for Training Initiative on Hands-Only CPR 2Health News:Jane M. Knight Recognized By Strathmore's Who's Who Worldwide Publication 2
The inner wall of the tube is coated with spray-dried lithium, ammonium or sodium heparin. These additives are anti-coagulants, which activate anti-thrombins, thus blocking the coagulation cascade of...
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: